Category: secondary offering

Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5B Stock Repurchase

TARRYTOWN, NY (STL.News) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the commencement of an underwritten public secondary offering of its common stock through which Sanofi (NASDAQ: SNY) intends to exit its investment in Regeneron shares.  The shares being offered by…